Sendur, S. N. Et Al. 2022. Specific FSTL1 polymorphism may determine the risk of cardiomyopathy in patients with acromegaly.. Acta cardiologica , vol.77, no.4 , 350-359.

Sendur, S. N., Hazirolan, T., Aydin, B., Lay, İ., Alikasifoglu, M., & Erbas, T., (2022). Specific FSTL1 polymorphism may determine the risk of cardiomyopathy in patients with acromegaly.. Acta cardiologica , vol.77, no.4, 350-359.

Sendur, SÜLEYMAN Et Al. "Specific FSTL1 polymorphism may determine the risk of cardiomyopathy in patients with acromegaly.," Acta cardiologica , vol.77, no.4, 350-359, 2022

Sendur, SÜLEYMAN N. Et Al. "Specific FSTL1 polymorphism may determine the risk of cardiomyopathy in patients with acromegaly.." Acta cardiologica , vol.77, no.4, pp.350-359, 2022

Sendur, S. N. Et Al. (2022) . "Specific FSTL1 polymorphism may determine the risk of cardiomyopathy in patients with acromegaly.." Acta cardiologica , vol.77, no.4, pp.350-359.

@article{article, author={SÜLEYMAN NAHİT ŞENDUR Et Al. }, title={Specific FSTL1 polymorphism may determine the risk of cardiomyopathy in patients with acromegaly.}, journal={Acta cardiologica}, year=2022, pages={350-359} }